NCT01912053View on ClinicalTrials.gov

Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

November 30, 2017

Conditions

Cholangiocarcinoma

Interventions

RADIATION

Therasphere® in association with Gemcitabine and Cisplatin

Therasphere® is a radioelement

Trial Locations (7)

34295

Hôpital saint-Eloi, Montpellier

35042

Centre Eugene Marquis, Rennes

44093

CHU- Hotel Dieu, Nantes

54000

CHU Nancy - Hôpital Brabois, Nancy

92118

Hôpital Beaujon - Service de Chirurgie, Clichy

94010

Hôpital Henri Mondor, Créteil

Unknown

CHU Poitiers, Poitiers

All Listed Sponsors

lead

Center Eugene Marquis

OTHER

NCT01912053 - Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma | Biotech Hunter | Biotech Hunter